ArticleDiabetology international2021

Effect of linagliptin, a dipeptidyl peptidase-4 inhibitor, compared with the sulfonylurea glimepiride on cardiovascular outcomes in Asians with type 2 diabetes: subgroup analysis of the randomized CAROLINA® trial.

Takashi Kadowaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.